AstraZeneca AB (manufacturing, filling, quality control, labeling, secondary packaging and batch release)
UkraineAll drugs from this manufacturer
-
The drug is used for the treatment of persistent bronchial asthma, as well as for the treatment of moderate to severe chronic obstructive pulmonary disease (COPD).
Dosage form: powder for inhalation
Active substance Dosage budesonide 100 mcg ATC: R03BA02
-
The drug is used for the treatment of persistent bronchial asthma, as well as for the treatment of moderate to severe chronic obstructive pulmonary disease (COPD).
Dosage form: powder for inhalation
Active substance Dosage budesonide 200 mcg ATC: R03BA02
-
The drug is prescribed for the regular treatment of bronchial asthma. It is used either for continuous maintenance or for both prevention and rapid relief of symptoms.
Dosage form: powder, inhalation, metered
Active substance Dosage budesonide 80 mcg formoterol 4.5 mcg ATC: R03AK07
-
The drug is prescribed to adults and children from 12 years of age for the regular treatment of bronchial asthma, as well as to adults from 18 years of age for the symptomatic treatment of chronic obstructive pulmonary disease (COPD).
Dosage form: powder, inhalation, metered
Active substance Dosage budesonide 160 mcg formoterol 4.5 mcg ATC: R03AK07
-
The drug is prescribed for the regular treatment of bronchial asthma in adults and children aged 12 years and older, as well as for the symptomatic treatment of adults with chronic obstructive pulmonary disease (COPD).
Dosage form: powder, inhalation, metered
Active substance Dosage budesonide 320 mcg formoterol 9.0 mcg ATC: R03AK07